When was MGI founded?

MGI was founded in 2016 and raised its 1st funding round 3 years after it was founded.

Where is MGI located?

MGI is headquartered in Shenzhen, China.

How many employees does MGI have?

As of Mar 31, 2026, the latest employee count at MGI is 1313.

Is MGI a funded company?

MGI is a funded company, having raised a total of $1B across 2 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on May 2019.

When was the latest funding round of MGI?

MGI's latest funding was a $***** Series B round on May 28, 2020, with participation from 11 investors.

Where does MGI rank among its competitors?

MGI ranks 6th amongst 353 active competitors, of which 52 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Eclipse Bio, which secured $4.91M in Nov, 2025.

Who are the top competitors of MGI?

MGI's top competitors include Illumina, Quanterix and BioLife Solutions. Among them, Eclipse Bio secured the most recent funding round in November, 2025.

MGI - 2026 Company Profile, Team, Funding & Competitors

MGI is a series B company based in Shenzhen (China), founded in 2016 by Wang Jian, Liu Siqi, Yang Huanming and Yu Jun. It operates as a Provider of gene sequencing instruments, reagents, equipment, and related products. MGI has raised $1B in funding from investors like Guotai Junan Securities, CoStone Capital and IDG Capital. The company has 353 active competitors, including 52 funded and 55 that have exited. Its top competitors include companies like Illumina, Quanterix and BioLife Solutions.

Company Details

Provider of gene sequencing instruments, reagents, equipment, and related products. The company has multi-omics platforms which include robotic ultrasound systems, sequencers, and automation systems for life science research, agriculture, precision medicine, and healthcare. It also has sequencing reagents, enzymes, an instrument for microbial detection, analyzers, and others.

Website: mgi-tech.com
Social
Email ID: *****@mgi-tech.com
Phone Number: +86 **********

Key Metrics

Founded Year

2016

Location

Shenzhen, China

Stage

Series B

Total Funding

$1B in 2 rounds

Latest Funding Round

Series B, May 28, 2020, $*****

Investors

Guotai Junan Securities & 13 more

Ranked

6^th among 353 active competitors

Employee Count

1,313 as on Mar 31, 2026

Investment & Acquisitions

Genepoint Biological Technology & 1 more

Similar Companies

Illumina & 408 more

View MGI's full profile

MGI has raised a total funding of $1B over 2 rounds. Its first funding round was on May 2019. Its latest funding round was a Series B round on May 28, 2020 for $*****. 11 investors participated in its latest round. MGI has 14 institutional investors.

Here is the list of recent funding rounds of MGI:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 28, 2020	1105071	Series B	3440241	3446655	8635810	5167600
May 2019	7130169	Series A	7356488	7894026	8491965	1912299

Access funding benchmarks and valuations. Sign up today!

View details of MGI's funding rounds and investors

The founders of MGI are Wang Jian, Liu Siqi, Yang Huanming and Yu Jun.

Here are the details of MGI's key team members:

Wang Jian: Co-Founder of MGI.
Liu Siqi: Co-Founder of MGI.
Yang Huanming: Co-Founder of MGI.
Yu Jun: Co-Founder of MGI.

View details of MGI's Founder profiles and Board Members

MGI's employee count trend

MGI has 1,313 employees as of Mar 26. Here is MGI's employee count trend over the years:

Uncover MGI's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of MGI include Illumina, Quanterix and BioLife Solutions. Here is the list of Top 10 competitors of MGI, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Illumina 1993, San Diego (United States), Public	Developer of technologies for analysis of genetic variation and function	$28M	Chevron Technology Ventures, Dow Chemical Company ... & 32 others	71/100
2nd	Quanterix 2007, Cambridge (United States), Public	Developer of assay kits for ultra-sensitive biomarker detection	$99.5M	T. Rowe Price, Hercules Capital & 15 others	71/100
3rd	BioLife Solutions 1987, Bothell (United States), Public	Developer of cell and gene therapies with the integrity of a single cell	-	-	67/100
4th	Arbor Biotechnologies 2016, Cambridge (United States), Series C	Provider of genomic technologies and drug discovery platform	$304M	TCG Crossover, Temasek & 27 others	65/100
5th	Biocare Medical 1997, Concord (United States), Acquired	Manufacturer of primary antibodies and instruments for immunohistochemistry applications	$85M	Excellere Partners, GHO Capital Partners & 3 others	65/100
6th	MGI 2016, Shenzhen (China), Series B	Provider of gene sequencing instruments, reagents, equipment, and related products	$1B	CoStone Capital, Guotai Junan Securities ... & 12 others	64/100
7th	Mapi Pharma 2008, Ness Ziona (Israel), Series B	Clinical stage pharmaceutical company developing extended release versions of generic drugs.	$60M	aMoon, Shavit Capital & 3 others	62/100
8th	Eclipse Bio 2017, San Diego (United States), Series A	Developer of cell-free immunoassay	$18.9M	Alexandria, IGlobe Partners & 2 others	61/100
9th	Siemens Healthineers 1847, Forchheim (Germany), Public	Developer of AI-based medical diagnostic products for the healthcare sector	-	Skyviews Life Science, Europa & 1 others	60/100
10th	Bio-Techne 1981, Minneapolis (United States), Public	Developer of biotech reagents, instruments and clinical diagnostic products	-	HHS	59/100